RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AUPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Aurinia Pharmaceuticals Inc
(Updated on Mar 28, 2024)

Sell candidate since Feb 13, 2024 Loss -35.60% PDF

The Aurinia Pharmaceuticals Inc stock price gained 0.200% on the last trading day (Thursday, 28th Mar 2024), rising from $5.00 to $5.01. During the last trading day the stock fluctuated 1.41% from a day low at $4.97 to a day high of $5.04. The price has been going up and down for this period, and there has been a -1.57% loss for the last 2 weeks. Volume fell on the last day by -52 thousand shares and in total, 1 million shares were bought and sold for approximately $6.75 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -42.27% during the next 3 months and, with a 90% probability hold a price between $2.57 and $3.47 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AUPH Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 1.62%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aurinia Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.83. On a fall, the stock will find some support from the short-term average at $5.01. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Aurinia Pharmaceuticals Inc stock

Aurinia Pharmaceuticals Inc finds support from accumulated volume at $5.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0700 between high and low, or 1.41%. For the last week, the stock has had daily average volatility of 2.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AUPH) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Aurinia Pharmaceuticals Inc to open at $5.01, and during the day (based on 14 day Average True Range), to move between $4.78 and $5.24, which gives a possible trading interval of +/-$0.225 (+/-4.50%) up or down from last closing price. If Aurinia Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 9.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.00 (0.20%) than the resistance at $5.85 (16.77%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aurinia Pharmaceuticals Inc stock A Buy?

Aurinia Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.822 Sell Candidate Unchanged

Predicted Opening Price for Aurinia Pharmaceuticals Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$5.01 ( 0.0665%) $5.01

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AUPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.08 1.33 %
R2 5.05 0.797 %
R1 5.03 0.467 %
Current price: 5.01
Support S1 4.98 -0.600 %
S2 4.96 -0.93 %
S3 4.94 -1.46 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.02 20.16 %
R2 6.00 19.76 %
R1 5.85 16.77 %
Current price 5.01
Support S1 5.00 -0.200%
S2 4.99 -0.399%
S3 4.97 -0.798%

FAQ

What is the symbol for Aurinia Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Aurinia Pharmaceuticals Inc is AUPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aurinia Pharmaceuticals Inc Stock.

What's the current price of Aurinia Pharmaceuticals Inc Stock?
As of the end of day on the 2024-03-28, the price of an Aurinia Pharmaceuticals Inc (AUPH) share was $5.01.

What is the 52-week high and low for Aurinia Pharmaceuticals Inc Stock?
The 52-week high for Aurinia Pharmaceuticals Inc Stock is $12.42 and the 52-week low is $4.85.

What is the market capitalization of Aurinia Pharmaceuticals Inc Stock?
As of the 2024-03-28, the market capitalization of Aurinia Pharmaceuticals Inc is 723.09M.

When is the next earnings date for Aurinia Pharmaceuticals Inc?
The upcoming earnings date for Aurinia Pharmaceuticals Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT